source
- Cellular Intelligence hires neurologist to assess Novo Nordisk's Parkinson's stem cell programCellular Intelligence, an AI‑driven biotech, announced it is evaluating Novo Nordisk's Parkinson's stem cell therapy after Novo shut down its cell therapy unit. The company engaged neurologist and…
- AstraZeneca shares tumble after heart drug trial failsAstraZeneca's stock fell in early trading on Thursday after the company disclosed that its experimental heart disease therapy, developed with Ionis Pharmaceuticals, did not meet primary endpoints i…